Journals / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 1

The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study

Pages
97–104
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study revealed that there might be a potential link between HS and IBS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder in which one experiences abdominal pain, tension, cramping, bloating, and changes in the form and frequency of defecation, without an underlying organic disease.
📊
Key Findings & Data:Results: According to the Rome IV diagnostic criteria, 54 (67.50%) of 80 HS patients and 23 (28.75%) of 80 control group were diagnosed with IBS.
💡
Conclusion & Impact:Conclusion: Our study revealed that there might be a potential link between HS and IBS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder in which one experiences abdominal pain, tension, cramping, bloating, and changes in the form and frequency of defecation, without an underlying organic disease. Many skin diseases have been reported to be more common in people with functional bowel disease. To our knowledge, however, no previous study investigated the potential relationship between hidradenitis suppurativa (HS) and IBS. In this study, we aimed to examine the potential association between IBS and HS. Materials and methods: Patients with HS and healthy subjects were enrolled in this cross-sectional study. All participants were assessed for the presence of IBS. ROME IV criteria were used to identify IBS cases. Hurley staging, modified Sartorius score, and physician’s global assessment score were applied to define clinical severity and staging of HS. Results: According to the Rome IV diagnostic criteria, 54 (67.50%) of 80 HS patients and 23 (28.75%) of 80 control group were diagnosed with IBS. The frequency of IBS was statistically significantly higher in the patient group than in the control group (P < 0.001). No statistically significant difference was found between the two groups in terms of abnormal stool frequency and family history of IBS (P = 0.28, P = 0.862, respectively). Abnormal stool form, mucus in stool, abdominal distension, feeling of incomplete evacuation were statistically significantly higher in HS patients compared to the controls (P = 0.01, P = 0.02, P < 0.001, P = 0.001, respectively). Conclusion: Our study revealed that there might be a potential link between HS and IBS.

🔖

Cite This Article

DURSUN, R., DEMİRBAŞ, G. U., DEMİRBAŞ, A., ATASOY, M., ELMAS, Ö. F., EKER, H., LOTTİ, T., TÜRSEN, Ü. (2022). The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 1, 97–104. https://ajindex.com/articles/609213

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V et al. Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore. Journal of the European Academy of Dermatology and Venereology 2020
  2. 34(8):1815-1821. doi: 10.1111/jdv.16328 2. Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clinical, Cosmetic and Investigational Dermatology 2017
  3. 105–115. doi: 10.2147/CCID.S111019 3. Alatas ET, Biteker M, Alatas OD. Epicardial fat thickness is increased and associated with disease severity in hidradenitis suppurativa. Archives of Dermatological Research 2020
  4. 312 (7):467-472. doi: 10.1007/s00403-019-02032-6 4. Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence. Journal of The American Academy of Dermatology International 2020
  5. 1(1): 62-72.doi: 10.1016/j. jdin.2020.05.005 5. List EK, Pascual JC, Zarchi K, Nürnberg BM, Jemec GBE. Mast cells in hidradenitis suppurativa: a clinicopathological study. Archives of Dermatological Research 2019
  6. 311(4):331- 335. doi: 10.1007/s00403-019-01910-3 6. Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: implication of the skin-gut axis. Australasian Journal of Dermatology 2019
  7. 60 (2):90-98. doi: 10.1111/ajd.12909 7. Balato A, Caiazzo G, Annunziata MC, Marasca C, Scala E et al. Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology 2019
  8. 33(1):43-45. doi: 10.1111/jdv.15160 8. Nagai S, Kurebayashi Y, Koyasu S. Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation. Annals of the New York Academy of Sciences 2013
  9. 1280(1):30-34. doi: 10.1111/nyas.12059 9. Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. The New England Journal of Medicine 2017
  10. 376(26):2566-2578. doi: 10.1056/NEJMra1607547 10. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clinical Gastroenterology and Hepatology 2012
  11. 10 (7):712-721. doi: 10.1016/j.cgh.2012.02.029 11. Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. The Lancet Gastroenterology and Hepatology 2016
  12. 1(2):133-146. doi: 10.1016/S2468- 1253(16)30023-1 12. Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regu